Fraunhofer ITEM is developing physiologically based kinetic models to calculate how inhaled substances are absorbed, distributed, metabolized, and excreted by the human body.
Published
Signal category
Research & Knowledge
Quote
“Another focus at Fraunhofer ITEM is the development of physiologically based kinetic (PBK) models”
— Fraunhofer ITEM team
Company
Fraunhofer ITEM
PIONEERS FOR SUSTAINABLE HEALTH
- Industry
- Research Services
- Location
- Hannover, DE
- Company size
- 211 employees
The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of more than 70 institutes of the Fraunhofer-Gesellschaft, the world’s leading applied research organization. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on respiratory research, the R&D portfolio at our Hannover headquarters comprises three business areas: Drug Development, Chemical Safety and Translational Biomedical Engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.
Founded 1981